We evaluated three commercially available immunoradiometric assays for serum ferritin, with particular emphasis on the statistical validity of the results. The data show that it was unusual (a) for dose/response relationships of the standards to be linear over the whole concentration range suggested by the manufacturers and (b) for dose/response relationships of test sera to parallel those of the standards. These findings cast doubt on the ability of any of the assays reliably to discriminate small differences in ferritin concentrations. Nevertheless, all three methods gave reproducible results, but this reflects technical expertise rather than accuracy of the results per se. The method based on liver ferritin as tracer detected less of the iron-binding protein than those based on spleen ferritin, despite significant cross reactivity of the two antibodies. The data show that none of the three assays was entirely satisfactory: the relation of log concentration to response frequently deviated significantly from linearity, and test sera generally produced log concentration/response relationships with slopes that differed significantly from those of the standards. These findings cast doubt on the ability of these assays accurately to discriminate differences in ferritin concentrations between samples. The reproducibility of all the assays, as determined from repetitive measurements at a standard dilution, was within acceptable limits.
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Ferritin
was first-recognized as a normal, physiological constituent of human serum in 1972 (1) . Since then it has come to be recognizedthat concentrationsof ferritin inserum accurately reflectbody-iron stores in several clinical situations, particularly those involvingchanges in iron metabolism (see,for example, reference2 for a recent review).To satisfy the demand for what is perceived as an informative clinical test, several commercial assays for ferritin are now available.
The object of this study was to evaluate three immunoradiometric assays (IRMA) for serum ferritin, with particular emphasis on statistical performance.
The data show that none of the three assays was entirely satisfactory: the relation of log concentration to response frequently deviated significantly from linearity, and test sera generally produced log concentration/response relationships with slopes that differed significantly from those of the standards. These findings cast doubt on the ability of these assays accurately to discriminate differences in ferritin concentrations between samples. The reproducibility of all the assays, as determined from repetitive measurements at a standard dilution, was within acceptable limits.
Materials and Methods
We used IRMA 
Results
Preliminary investigations
were directed at determining the reproducibility of results obtained when a sample was run repeatedly in the same assay. A serum selected without conscious bias was assayed 10 times in all assays, both with and without a 10-fold prior dilution. The results are summarized in Table 2 . Coefficients of variation (CV) varied between 2%
(Ramco) and 5.9% (Ventrex) for measurements made on prediluted serum, or between 3.6% (Ramco) and 9.1% (Ventrex) on the same serum assayed without prior dilution. Two-way analysis of variance of the results summarized in Table 2 followed by a post-test comparison by use of Tukey's Honestly Significantly Different method (5) demonstrated that the mean ferritin titers showed significant differences both between assays and between dilutions. Furthermore, the presence of a significant interaction indicated that the differences between titers in prediluted and undiluted sera were not constant across manufacturers. Thus, the apparent ferritin concentrations were a function of the particular assay and of the dilution used in that assay. The quality-control samples consistently gave results within the ranges predicted by the manufacturers. Figure 1 shows representative log concentration/response relationships for the standards in each assay. Results from a serum (different from that used for the results in Table 2, but representative of all 20 investigated) studied in all three assays after a range of predilutions are also documented. With the Ramco assay ( Figure 1A) , the log concentration/ response relationships for the standard showed significant deviations from linearity when the results of all six recommended concentrations were employed in the analysis. However, no significant deviations from linearity were observed over the concentration range 5-500 zgfL. When the results of the Corning assay ( Figure 1B ) were expressed as a linear response all possible ranges of three produced log concentration/response relationships which showed significant deviations from linearity. Deviations from linearity were reduced, but were still significant, if the data were recalculated on the basis of log concentration/logit response.
Only over the range 50-1000 g/L-the four highest concentrations used in constructing the standard curve-did the log concentration/response relationship to the ferritin standard in the Ventrex assay ( Figure 1C ) not show significant deviations from linearity. Note: The y-axis varies according to themethod of expressing the results recommended by the manufacturer important clinically in distinguishingtwo sera each of which have low ferritin titers. As titers approach the sensitivity threshold of the assay,confidence limitsof the measurements are generallylarger.Thus a greater differencebetween two measured titerswould be necessary forstatistical certainty.
In thiscontext the reproducibility of the measurements (Table   2 ) and acceptable data from the assay of the quality-control samples reflects technicalexpertiserather than accuracy of the resultsper se.The generally smaller CV with the Ramco as compared with the Corning or Ventrex assays is probably a result of the steep dose/relationships observed with this kit. In these studies the so-called high-dose "hook" effect (11) was not demonstrated.
However, it is another potential problem in many bio-(4) and immunoassay systems (11). Because it is not possible to distinguish whether the one-dose "test" response is on the ascending or decending limb of the 
Discussion
A basic principle in the measurement of any material that cannot be quantitated on the basis of a physical property (e.g., weight or volume) is that dose/response relationships to a generally acceptable standard and to the test substance not show significant deviations from linearity or from parallelism to one another (4, 6). (Indeed, it has been stated3 that the standard in such assays should be especially selected to produce dose/response relationships parallel to those of the test samples). Only if these criteria are met (together with others related to the slopes of the relationships, which were easily fulfilled in the current evaluations) can the potency of the test solution be stated with any degree of certainty and its biological (or immunological) similarity to the standard material confirmed.
In practice, dose/response relationships to both standard and test materials are seldom constructed in a routine clinical environment, for a variety of reasons. Nevertheless, these basic fundamentals of bio-or immunoassays are assumed in the one-dose "tests" (4) commonly used. The studies reported herein emphasize the care with which the results of one-dose "tests" should be interpreted in the absence of details regarding dose/response relationships.
In all of the assays evaluated the standard curves generally showed significant deviations from linearity over the concentration range recommended by the manufacturers. This problem could be overcome, at least in the Ramco and Ventrex assays, by omitting the lowest and/or highest concentrations from the calculations (Figure 1 ). This has the result that accurate data will be obtained only over a narrower concentration range than implied by the manufacturers. Test sera frequently produced dose/response relationships which did not differ significantly from linearity. However, parallelism of these relationships to those of the standards was such a rare occurrence that it would appear that our findings, while based on a relatively small sample size (n = 20), are more generally applicable. One possible explanation for these deviations from parallelism is that human serum ferritin is antigenically distinct from the human spleen or liver ferritins used as tracers in the assays. The demonstration of several iso-ferritins in human serum makes this hypothesis plausible (7, 8) . Alternative explanations involve the interference of other serum proteins in the antigen-antibody reaction. In our experience the combination of significant deviations from linearity and from parallelism result in an error of approximately ±50 g/L (for a one-dose "test") in sera with ferritin concentrations normalized to 300 j.tg/L (i.e., ± 17%; see also Table 2 ). With 95%
confidence limits typically ranging from 80 to 125% of the expected value (100%) (4, 10) and technical reproducibility on the order of 5% (Table 2) , it can be calculated that it is improbable that ferritin concentrations in two samples differing by less than two-fold could be considered statistically significant.
This may not be particularly critical, given the wide range of "normal" serum ferritin concentrations (10), although data of doubtful statistical validity from the onedose "tests" may have contributed to this apparent wide range. However, it castsdoubt on the ability of the commercially-available assays to discriminate small differences in ferritin concentrations.
This conclusion may be particularly potency of 10-foldor greater could be encountered (4, 11) .
Despite the potential variability, a good correlation was demonstrated between the results of the three assays (current study) and between the Ramco (9) and the Hoechst (12) assays and standard laboratory methods. However, both previous studies (9, 12) demonstrated that the commerciallyavailableassays detected significantly less ferritin than standard laboratory procedures. The present results ( Table  2 ) confirm previous observations (12, 13) that assays based on liver ferritin as a tracer (Ventrex) givelower concentrations for serum ferritin than those in which spleen ferritin is used as the tracer (Ramco and Corning). The reasonsfor this are unclear, particularly as human spleen ferritin antibody strongly cross-reactswith human liver ferritin, and vice versa.
This observation supports the manufacturer's claim and has been independently demonstrated previously (13) . In the present studies, however, the "crossover" dose/response relationships seemed to retain the characteristics of the antibody (particularly in terms of concentration ranges and slopes) much more so than of the antigen.
